Big Deals: Canada-based Cynapsus Therapeutics Inc.
Troutman Sanders was mentioned in the “Big Deals” section of Lexpert Magazine’s October 2015 edition for advising Canada-based Cynapsus Therapeutics Inc. with its United States initial public offering of 5,175,000 common shares sold to the public at US$14.00 per share for gross proceeds of approximately U.S.$72.5 million and its listing on the NASDAQ Global Market. The offering was underwritten by Bank of America Merrill Lynch, Normura and Noble Life Science Partners.
Corporate partner Tom Rose was the lead on a team of Troutman Sanders attorneys – Heather Ettinger (IP), Mark Goldsmith (Tax), Amie Broder (Tax), Dave Meyers (Corporate), Shona Smith (Corporate), Lisa Raines (Corporate), Kristen O’Connor (Corporate) and Dan Howell (Corporate) and many others – who assisted Cynapsus on the deal.